Farms.com Home   News

Canada launches public consultations on tariff rate quotas for supply-managed goods

OTTAWA - Global Affairs Canada has launched public consultations on how it allocates and administers tariff rate quotas for a number of supply-managed poultry and dairy products.
 
The government is looking to hear from both individuals and organizations via an online questionnaire found on its website.
 
A tariff rate quota (TRQ) is an import mechanism that allows a certain amount of a specific product to be imported at a low or zero duty rate, while anything above that is generally charged a much higher rate.
 
The survey allows Canadians to choose from two dozen products to comment on, including chicken, eggs, cheese and butter.
 
It asks questions about what the preferred method of allocation would be for TRQs, whether new entrants should face different eligibility criteria, and whether there should be a cap on how much of the quota one allocation holder can receive.
 
Survey takers can weigh in on whether a portion of the allocation should be reserved for specific demographics or other categories, like women-owned businesses; whether transfers should be allowed; and what, if any, restrictions should be considered for auctions.
Source : FCC

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.